Interim agreement under FSS schedule 65 i b drugs, pharmaceuticals, & hematology related products

Active Federal Supply Schedule Awarded Last action

Contract number
36F79726D066E
Awardee
Awarding agency
Task orders
0

Award facts

Last date to order 11% complete
IDV ceiling
$25,000.00
Award type
Multiple award
Who can order
All agencies
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Fixed Price with Economic Price Adjustment

Award details come from SAM.gov/FPDS.

About this IDV

GSA awarded Travere Therapeutics, Inc. a Federal Supply Schedule contract under Schedule 65 IB (Drugs, Pharmaceuticals, & Hematology Related Products) on September 29, 2026, with a ceiling value of $25,000.00 and ultimate completion date of March 28, 2027. This is an interim agreement issued to support the Veterans Integrated Service Network 12.

Travere operates as a San Diego-based biopharmaceutical manufacturer specializing in rare-disease therapeutics for kidney and liver disorders. Under the Pharmaceuticals and Drugs FSS schedule, the company supplies pharmaceuticals including Thiola (tiopronin) for cystinuria, Filspari for primary glomerulonephritis, Cholbam (chenodeoxycholic acid) for progressive familial intrahepatic cholestasis and bile acid synthesis defects, and Chenodal (chenodeoxycholic acid) for gallstone prevention in patients with liver dysfunction. Ordering activity under this schedule has historically consisted of blanket purchase agreements established by the VA National Acquisition Center anchoring the portfolio, with recurring delivery orders placed by individual Veterans Integrated Service Networks against those BPAs. VISN 12 holds 11 awards worth $25.6 million in combined potential value, with representative recent activity including monthly delivery orders in the $11,000 to $31,000 range for specific medications and quantities. Place of performance includes San Diego (headquarters), Foster City, Monroeville, Pennsylvania, and Bartlett, Tennessee.

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00001 $0
Original award $0

Quick answers

Who was awarded contract 36F79726D066E?

36F79726D066E was awarded to Travere Therapeutics, Inc. by Veterans Integrated Service Network 12 (Veterans Health Administration) on September 29, 2026.

How much is contract 36F79726D066E worth?

36F79726D066E's own ceiling is $25,000.

Who can order from contract 36F79726D066E?

36F79726D066E is a multiple award federal supply schedule. All agencies can place orders on it.

Was contract 36F79726D066E competed?

The extent of competition for 36F79726D066E was full and open competition.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV